# From the Editor-in-Chief's Desk: Benchmarking Clinically Meaningful Improvement in the Treatment of Tourette Syndrome.

**DOI:** 10.1177/10445463251379865
**Journal:** Journal of child and adolescent psychopharmacology
**Date:** 2025-09-15
**Authors:** ['Paul ECroarkin']
**Category:** tourette_syndrome
**Source:** pubmed
**Scraped by:** agent_a
**Scraped at:** 2025-10-21T10:44:57.576152
**Source URL:** https://pubmed.ncbi.nlm.nih.gov/?term=10.1177/10445463251379865

## Abstract



## Full Text Content

Filters applied.Clear filtersEditorialJ Child Adolesc PsychopharmacolActionsSearch in PubMedSearch in NLM CatalogAdd to Search.2025 Oct;35(8):439-440.doi: 10.1177/10445463251379865.Epub 2025 Sep 15.From the Editor-in-Chief's Desk: Benchmarking Clinically Meaningful Improvement in the Treatment of Tourette SyndromePaul E Croarkin1AffiliationsExpandAffiliation1Mayo Clinic Children's Research Center, Mayo Clinic, Rochester, Minnesota, USA.PMID:40951991DOI:10.1177/10445463251379865Item in ClipboardEditorialFrom the Editor-in-Chief's Desk: Benchmarking Clinically Meaningful Improvement in the Treatment of Tourette SyndromePaul E Croarkin.J Child Adolesc Psychopharmacol.2025 Oct.Show detailsDisplay optionsDisplay optionsFormatAbstractPubMedPMIDJ Child Adolesc PsychopharmacolActionsSearch in PubMedSearch in NLM CatalogAdd to Search.2025 Oct;35(8):439-440.doi: 10.1177/10445463251379865.Epub 2025 Sep 15.AuthorPaul E Croarkin1Affiliation1Mayo Clinic Children's Research Center, Mayo Clinic, Rochester, Minnesota, USA.PMID:40951991DOI:10.1177/10445463251379865Item in ClipboardFull text linksCiteDisplay optionsDisplay optionsFormatAbstractPubMedPMIDNo abstract availablePubMed DisclaimerPublication typesEditorialActionsSearch in PubMedSearch in MeSHAdd to SearchLinkOut - more resourcesFull Text SourcesAtypon

---
*This content was automatically scraped by Webscraping Agent A*
